eicosapentaenoic acid ethyl ester has been researched along with Overweight in 2 studies
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawada, H | 1 |
| Ando, H | 1 |
| Takashima, H | 1 |
| Waseda, K | 1 |
| Shimoda, M | 1 |
| Ohashi, H | 1 |
| Suzuki, A | 1 |
| Sakurai, S | 1 |
| Nakano, Y | 1 |
| Amano, T | 1 |
| Pérez-Echarri, N | 1 |
| Pérez-Matute, P | 1 |
| Marcos-Gómez, B | 1 |
| Martínez, JA | 1 |
| Moreno-Aliaga, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cellular and Molecular Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) on Adipose Tissue: Potential Application in Human Obesity[NCT01138774] | 103 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for eicosapentaenoic acid ethyl ester and Overweight
| Article | Year |
|---|---|
Epidemiological Features and Clinical Presentations of Acute Coronary Syndrome in Young Patients.
Topics: Acute Coronary Syndrome; Adult; Age Factors; Aged; Arachidonic Acid; Eicosapentaenoic Acid; Female; | 2020 |
Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats.
Topics: Adipose Tissue, White; Animals; Apelin; Blood Glucose; Carrier Proteins; Diet; Eicosapentaenoic Acid | 2009 |